Review


DOI :10.26650/JARHS2020-S1-0013   IUP :10.26650/JARHS2020-S1-0013    Full Text (PDF)

COVID-19 Pandemia: Global Consequences for Oncology

Rejin Kebudi

People with cancer and cancer survivors, particularly those with compromised immune systems, are prone to infections and are at high risk for the new coronavirus 2019 (COVID-19) infection. The incidence and prevalence of the COVID-19 infection in cancer patients are higher than the general population according to data reported from China, where COVID-19 was first identified and other countries. Based on available evidence, children seem to be at a lower risk for COVID-19 than adults. Oncology specialists and other providers involved in diagnosis, treatment, and follow-up of patients with cancer must consider how to balance delay in cancer diagnosis or treatment against the risk for potential COVID-19 exposure. Patients, caregivers and hospital staff members should be keen on hand washing, correct use of masks. Healthcare workers should use the appropriate personal protective equipment. Physicians and nurses dedicated to Hematology-Oncology and Stem Cell Transplant Units shall not attend any COVID-19 patients or services. Guidelines provided by the Ministy of Health and international guidelines should be followed.

DOI :10.26650/JARHS2020-S1-0013   IUP :10.26650/JARHS2020-S1-0013    Full Text (PDF)

COVID-19 Pandemisi ve Dünyada Onkolojide Etkileri

Rejin Kebudi

Kanser tedavisi (kemoterapi, radyoterapi, kök hücre nakli, immünoterapi vd) gören veya yakın zamanda tedavisi bitmiş olan gerek erişkin, gerek çocuk hastalar bağışıklık sistemleri baskılandığından enfeksiyona duyarlıdırlar. Kanser tedavisi gören hastalar ve kanser geçirmiş olan kişiler COVID-19 pandemisinde riskli bir grubu oluşturmaktadırlar. Hastalığın ilk görüldüğü Çin'de ve diğer ülkelerde kanser hastalarında, genel populasyona oranla COVID-19 infeksiyonunun insidans ve prevalansının daha yüksek olduğu, komorbiditelerin olmasının da riski artırdığı bildirilmektedir. Çocukların erişkinlere oranla daha düşük riskte oldukları bildirilmektedir. Kanser hastalarının tanı, tedavi ve takibinde görev alan onkologlar ve idarecilerin hastaların tanı ve tedavilerinin devamını sağlarken, infeksiyona maruz kalmalarını önlemeleri önemlidir. Bu nedenle hastalar, onlara bakım veren yakınları ve sağlık çalışanları başta el yıkama ve cerrahi maske takmak olmak üzere gerekli kişisel korunma önlemlerine azami ölçüde dikkat etmelidir. Kanser hastalarıyla uğraşan hekim ve sağlık personelinin, COVID enfeksiyonu servislerinde çalıştırılmaması önerilir. Kanser hastalarının takip ve tedavi süreçlerinde COVID-19 enfeksiyonundan korunmada Sağlık Bakanlığının önerileri, ulusal ve uluslararası kılavuzlar güncel olarak takip edilmeli, bu önerilere göre hareket edilmelidir.


PDF View

References

  • 1. World Health Organization. Coronavirus Disease Pandemic. [online]. Website https:// www.who.int/emergencies/diseases/novelcoronavirus-2019 [02/05/ 2020] google scholar
  • 2. Stoecklin BS, Rolland P, Silue Y, Mailles A, Campese C et al. Investigation Team. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations, and control measures, January 2020. Eurosurveillance 2020;25(6):2000094. google scholar
  • 3. T.C. Sağlık Bakanlığı Korona Tablosu https:// covid19.saglik.gov.tr/ (02/05/ 2020) google scholar
  • 4. American Society of Clinical Oncology COVID-19 Resources https://www.asco.org/ asco-coronavirus-information (02/05/2020) google scholar
  • 5. Bouffet E, Challinor J, Sullivan M, Biondi A, Rodriguez-Galindo C, Pritchard-Jones K. Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences. Pediatric Blood and Cancer. 2020 Apr 2:e28327. doi: 10.1002/pbc.28327. [Epub ahead of print]. google scholar
  • 6. Michael Sullivan, Eric Bouffet, Carlos Rodriguez-Gallindo, Sandra Luna-Fineman, Muhammad Saghir Khan, Pam Kearns, Doug Hawkins, Julia Challinor, Lisa Morrissey, Jorg Fuchs, Karen Marcus, Adriana Balduzzi, Luisa Bassett, Miguela Caniza, Justin N Baker, Laila Hessissen, Rejin Kebudi, Richard Sullivan, Kathy Pritchard-Jones. The COVID-19 PANDEMIC: A Rapid Global response for Children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, St Jude Global and the WHO. , Pediatric Blood and Cancer, 2020 (in press) https://doi. org/10.22541/au.158777298.87289192/v2 google scholar
  • 7. Jazieh AR, Alenazi TH, Alhejazi A Al Safi F, Al Olayan A. Outcome of Oncology Patients Infected With Coronavirus. JCO Global Oncol 6: 471-475. google scholar
  • 8. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-337. google scholar
  • 9. Desai A, Sachdeva S, Parekh T, Desai R. COVID-19 and Cancer: Lessons from a pooled analysis. JCO Global Oncology 2020;557-559. https://doi.org/10.1200/GO.20.00097. google scholar
  • 10. Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z. Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak.Cancer Discovery . Published Online first on April 28, 2020; DOI: 10.1158/2159-8290.CD-20-0422. google scholar
  • 11. Miyashita H, Mikami T, Chopra N, Yamada T, Chernyavsky S, Rizk D, Cruz C, Do Patients with Cancer Have a Poorer Prognosis of COVID-19? An Experience in New York City., Annals of Oncology (2020), https://doi.org/10.1016/j. annonc.2020.04.006. google scholar
  • 12. Hasan Tezer, Tuğba Bedir Demirdağ. Novel coronavirus disease (COVID-19) in children Turk J Med Sci (2020);50:592-603. TÜBİTAK doi:10.3906/sag-2004-174 google scholar
  • 13. Dong Y, Mo X, Hu Y, Qi X, Jiang F et al. Epidemiology of COVID-19 among children in China. Pediatrics 2020. doi: 10.1542/peds.20200702. google scholar
  • 14. Ogimi C, Greninger AL, Waghmare AA, et al. Prolonged Shedding of Human Coronavirus in Hematopoietic Cell Transplant Recipients: Risk Factors and Viral Genome Evolution. J Infect Dis. 2017;216(2):203-209. google scholar
  • 15. Xu Y, Li X, Zhu B, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med. 2020;26(4):502-505. google scholar
  • 16. Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020. google scholar
  • 17. Hrusak O, Kalina T, Wolf J, et al. Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment. European Journal of Cancer. 2020;132:11-16. google scholar
  • 18. Sun D, Li H, Lu X-X, et al. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s observational study. World J Pediatr 2020 [Epub ahead of print]. google scholar
  • 19. Lazzerini M, Barbi E, Apicella A, Marchetti F, Cardinale F, Trobia G. Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health. 2020. 20. Kebudi R. Pediatric oncology in Turkey. Journal of pediatric hematology/oncology. 2012;34:S12-S14. google scholar
  • 21. Kutluk MT, Yesilipek A. Pediatric cancer registry Turkey: 2009-2016 (TPOG & TPHD). In: American Society of Clinical Oncology; 2017. google scholar
  • 22. Infectious Disease Society of America (IDSA) COVID-19 testing resources https://www. idsociety.org/news--publications-new/ articles/2020/idsa-statement-on-covid-19testing-recommendations/). google scholar
  • 23. Interim infection prevention and control recommendations for patients with confirmed coronavirus disease 2019 (COVID-19) or persons under investigation for COVID-19 in healthcare setting. Centers for Disease Control; 2020. https://www.cdc.gov/coronavirus/2019ncov/hcp/infection-control-recommendations. html (02/05/ 2020) google scholar
  • 24. Türk Pediatrik Onkoloji Grubu Derneği kanserli çocuklarda COVID-19 şüphesi yönetimi http:// www.tpog.org.tr/kanserli-cocuklarda-COVID19-suphesi-yonetimi (02/05/2020) google scholar
  • 25. Hatipoğlu N. The “new” problem of humanity: New coronavirus (2019-nCoV / COVID-19) disease. Med J Bakirkoy 2020;16(1):1-8. google scholar
  • 26. Chen ZM, Fu JF, Shu Q, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr. 2020. google scholar
  • 27. World Health Organisation. Maintaining a safe and adequate blood supply during the pandemic outbreak of coronavirus disease (COVID-19) WHO Interim guidance, March 2020. 2020; https://www.who.int/publications-detail/ maintaining-a-safe-and-adequateblood-supplyduring-the-pandemic-outbreak-of-coronavirusdisease-(covid-19). Accessed April 18, 2020. google scholar
  • 28. Schiffer CA, Bohlke K, Delaney M, et al. Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2018;36(3):283-299. google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Kebudi, R. (2020). COVID-19 Pandemia: Global Consequences for Oncology. Journal of Advanced Research in Health Sciences, 3(1), 99-105. https://doi.org/10.26650/JARHS2020-S1-0013


AMA

Kebudi R. COVID-19 Pandemia: Global Consequences for Oncology. Journal of Advanced Research in Health Sciences. 2020;3(1):99-105. https://doi.org/10.26650/JARHS2020-S1-0013


ABNT

Kebudi, R. COVID-19 Pandemia: Global Consequences for Oncology. Journal of Advanced Research in Health Sciences, [Publisher Location], v. 3, n. 1, p. 99-105, 2020.


Chicago: Author-Date Style

Kebudi, Rejin,. 2020. “COVID-19 Pandemia: Global Consequences for Oncology.” Journal of Advanced Research in Health Sciences 3, no. 1: 99-105. https://doi.org/10.26650/JARHS2020-S1-0013


Chicago: Humanities Style

Kebudi, Rejin,. COVID-19 Pandemia: Global Consequences for Oncology.” Journal of Advanced Research in Health Sciences 3, no. 1 (May. 2022): 99-105. https://doi.org/10.26650/JARHS2020-S1-0013


Harvard: Australian Style

Kebudi, R 2020, 'COVID-19 Pandemia: Global Consequences for Oncology', Journal of Advanced Research in Health Sciences, vol. 3, no. 1, pp. 99-105, viewed 26 May. 2022, https://doi.org/10.26650/JARHS2020-S1-0013


Harvard: Author-Date Style

Kebudi, R. (2020) ‘COVID-19 Pandemia: Global Consequences for Oncology’, Journal of Advanced Research in Health Sciences, 3(1), pp. 99-105. https://doi.org/10.26650/JARHS2020-S1-0013 (26 May. 2022).


MLA

Kebudi, Rejin,. COVID-19 Pandemia: Global Consequences for Oncology.” Journal of Advanced Research in Health Sciences, vol. 3, no. 1, 2020, pp. 99-105. [Database Container], https://doi.org/10.26650/JARHS2020-S1-0013


Vancouver

Kebudi R. COVID-19 Pandemia: Global Consequences for Oncology. Journal of Advanced Research in Health Sciences [Internet]. 26 May. 2022 [cited 26 May. 2022];3(1):99-105. Available from: https://doi.org/10.26650/JARHS2020-S1-0013 doi: 10.26650/JARHS2020-S1-0013


ISNAD

Kebudi, Rejin. COVID-19 Pandemia: Global Consequences for Oncology”. Journal of Advanced Research in Health Sciences 3/1 (May. 2022): 99-105. https://doi.org/10.26650/JARHS2020-S1-0013



TIMELINE


Submitted24.04.2020
Accepted03.05.2020
Published Online15.05.2020

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.